0000874716-24-000036.txt : 20240216
0000874716-24-000036.hdr.sgml : 20240216
20240216175544
ACCESSION NUMBER: 0000874716-24-000036
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20240214
FILED AS OF DATE: 20240216
DATE AS OF CHANGE: 20240216
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Hunt Nimrata
CENTRAL INDEX KEY: 0001800619
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-19271
FILM NUMBER: 24649853
MAIL ADDRESS:
STREET 1: IDEXX LABORATORIES, INC.
CITY: WESTBROOK
STATE: ME
ZIP: 04092
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: IDEXX LABORATORIES INC /DE
CENTRAL INDEX KEY: 0000874716
STANDARD INDUSTRIAL CLASSIFICATION: IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES [2835]
ORGANIZATION NAME: 03 Life Sciences
IRS NUMBER: 010393723
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: ONE IDEXX DRIVE
CITY: WESTBROOK
STATE: ME
ZIP: 04092-2041
BUSINESS PHONE: 2075560300
MAIL ADDRESS:
STREET 1: ONE IDEXX DRIVE
CITY: WESTBROOK
STATE: ME
ZIP: 04092-2041
FORMER COMPANY:
FORMER CONFORMED NAME: IDEXX CORP / DE
DATE OF NAME CHANGE: 19600201
4
1
wk-form4_1708124119.xml
FORM 4
X0508
4
2024-02-14
0
0000874716
IDEXX LABORATORIES INC /DE
IDXX
0001800619
Hunt Nimrata
ONE IDEXX DRIVE
WESTBROOK
ME
04092
0
1
0
0
Executive Vice President
0
Common Stock
2024-02-14
4
M
0
126
0
A
11193.2345
D
Common Stock
2024-02-14
4
M
0
173
0
A
11366.2345
D
Common Stock
2024-02-14
4
M
0
161
0
A
11527.2345
D
Common Stock
2024-02-14
4
M
0
204
0
A
11731.2345
D
Common Stock
2024-02-14
4
A
0
208
0
A
11939.2345
D
Common Stock
2024-02-14
4
F
0
263
560.56
D
11676.2345
D
Common Stock
160
I
jointly with spouse
Non-Qualified Stock Option (right-to-buy)
560.56
2024-02-14
4
A
0
5407
0
A
2034-02-14
Common Stock
5407
5407
D
Incentive Stock Option (right-to-buy)
560.56
2024-02-14
4
A
0
178
0
A
2034-02-13
Common Stock
178
178
D
Restricted Stock Unit
2024-02-14
4
A
0
1204
0
A
Common Stock
1204
1204
D
Restricted Stock Unit
2024-02-14
4
M
0
126
0
D
Common Stock
126
0
D
Restricted Stock Unit
2024-02-14
4
M
0
173
0
D
Common Stock
173
0
D
Restricted Stock Unit
2024-02-14
4
M
0
161
0
D
Common Stock
161
160
D
Restricted Stock Unit
2024-02-14
4
M
0
204
0
D
Common Stock
204
408
D
Restricted Stock Unit
2024-02-14
4
M
0
208
0
D
Common Stock
208
621
D
Includes a total of 51.95 shares purchased under the Issuer Employee Stock Purchase Plan on March 31, 2023, June 30, 2023, September 29, 2023 and December 29, 2023.
Grant of option to buy shares of Issuer common stock that becomes exercisable in four annual installments beginning February 14, 2025.
Grant of option to buy shares of Issuer common stock that becomes exercisable in one installment on February 14, 2028.
Each restricted stock unit ('RSU') represents a contingent right to receive one share of Issuer common stock and vest in four annual installments beginning on February 14, 2025.
Each RSU represents a contingent right to receive one share of Issuer common stock. This RSU grant vested in five annual installments, beginning February 14, 2020.
Each RSU represents a contingent right to receive one share of Issuer common stock. This RSU grant vested in four annual installments, beginning February 14, 2021.
Each RSU represents a contingent right to receive one share of Issuer common stock. This RSU grant vests in four annual installments, beginning February 14, 2022.
Each RSU represents a contingent right to receive one share of Issuer common stock. This RSU grant vests in four annual installments, beginning February 14, 2023.
Each RSU represents a contingent right to receive one share of Issuer common stock. This RSU grant vests in four annual installments, beginning February 14, 2024.
/s/ Lily J. Lu, Attorney-in-Fact for Nimrata Hunt
2024-02-16